Cargando…
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
BACKGROUND: New generation hormone-therapies (NGHT) targeting the androgen signalling pathway are nowadays proposed to elderly patients with metastatic castration-resistant prostate cancer (CRPCa). The impact of these treatments on cognitive function has never been evaluated whereas cognitive impair...
Autores principales: | Lange, Marie, Laviec, Heidi, Castel, Hélène, Heutte, Natacha, Leconte, Alexandra, Léger, Isabelle, Giffard, Bénédicte, Capel, Aurélie, Dubois, Martine, Clarisse, Bénédicte, Coquan, Elodie, Di Fiore, Frédéric, Gouérant, Sophie, Bartélémy, Philippe, Pierard, Laure, Fizazi, Karim, Joly, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559794/ https://www.ncbi.nlm.nih.gov/pubmed/28814281 http://dx.doi.org/10.1186/s12885-017-3534-8 |
Ejemplares similares
-
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
por: Lange, Marie, et al.
Publicado: (2018) -
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial
por: Lange, Marie, et al.
Publicado: (2022) -
Effectiveness of a therapeutic patient education program in improving cancer pain management: EFFADOL, a stepped-wedge randomised controlled trial
por: Prevost, Virginie, et al.
Publicado: (2019) -
Multimodal Web-Based Intervention for Cancer-Related Cognitive Impairment in Breast Cancer Patients: Cog-Stim Feasibility Study Protocol
por: Binarelli, Giulia, et al.
Publicado: (2021) -
CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
por: Coquan, Elodie, et al.
Publicado: (2021)